The Influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on Organophosphate Poisoning and Its Therapy

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 1979 Jul 11

PMID 475595

Citations 14

Authors

B Boskovic

Affiliations

Soon will be listed here.

Abstract

The aim of the experiments was to obtain more information on the toxicity of organophosphates and protection against them. Pretreatment of mice with CBDP increased the s.c. toxicity of soman 19.1-fold, and its i.p. toxicity 17.8-fold. The protective effect of atropine and the oximes HS-3, HS-6 and HI-6 in soman poisoning was much greater in CBDP pretreated than in control animals. Atropine + HI-6 raised the s.c. LD50 of soman in the CBDP pretreated animals from 6.8 micrograms/kg to 166 micrograms/kg (PI = 24.3), but in control animals the i.p. LD50 was only raised from 370 micrograms/kg to 608 micrograms/kg (PI = 0.6). CBDP inhibited blood and brain AChE activity, but had no effect on aliesterase (AE) activity in plasma, liver and brain of mice in vivo. CBDP increased s.d. toxicities of sarin 11-fold, of tabun 5-fold and of VX 0.24-fold. The protective index of atropine + HS-3 in sarin poisoning, as in the case of soman poisoning, was much higher in CBDP pretreated than in control animals (20.1 : 13.6), only slightly higher in tabun poisoning (4.3 : 3.4) and in the case of VX poisoning lower in CBDP pretreated than in control animals (32 : 47). The results indicate that CBDP potentiates soman, sarin and tabun toxicities mainly by blocking their binding to non-specific sites in the body.

Citing Articles

Sarin-Induced Neuroinflammation in Mouse Brain Is Attenuated by the Caspase Inhibitor Q-VD-OPh.

Shah E, Grunwald Jr W, Garrett T, Brown T, Cool D J Pharmacol Exp Ther. 2023; 388(2):367-375.

PMID: 37918856 PMC: 10801781. DOI: 10.1124/jpet.123.001820.

Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam.

Marrero-Rosado B, de Araujo Furtado M, Schultz C, Stone M, Kundrick E, Walker K Epilepsia. 2018; 59(12):2206-2218.

PMID: 30368799 PMC: 6334636. DOI: 10.1111/epi.14582.

Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.

Baker P, Cole T, Cartwright M, Suzuki S, Thummel K, Lin Y Chem Biol Interact. 2012; 203(1):257-64.

PMID: 23085349 PMC: 3618534. DOI: 10.1016/j.cbi.2012.10.005.

Production of ES1 plasma carboxylesterase knockout mice for toxicity studies.

Duysen E, Koentgen F, Williams G, Timperley C, Schopfer L, Cerasoli D Chem Res Toxicol. 2011; 24(11):1891-8.

PMID: 21875074 PMC: 3221923. DOI: 10.1021/tx200237a.

Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.

Carletti E, Schopfer L, Colletier J, Froment M, Nachon F, Weik M Chem Res Toxicol. 2011; 24(6):797-808.

PMID: 21438623 PMC: 3118852. DOI: 10.1021/tx100447k.

References

Gordon J, LEADBEATER L . The prophylactic use of l-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoning. Toxicol Appl Pharmacol. 1977; 40(1):109-14. DOI: 10.1016/0041-008x(77)90122-3. View

OLDIGES H, SCHOENE K . [Pyridinium and imidazolium salts as antidotes for soman and paraoxon poisoning in mice]. Arch Toxikol. 1970; 26(4):293-305. View

Cohen J, WARRINGA M . Purification and properties of dialkylfluorophosphatase. Biochim Biophys Acta. 1957; 26(1):29-39. DOI: 10.1016/0006-3002(57)90050-1. View

Ramachandran B . Distribution of DF32P in mouse organs. II. The effect of prophylactically administered oximes and atropine on incorporation and toxicity. Biochem Pharmacol. 1966; 15(10):1577-87. DOI: 10.1016/0006-2952(66)90201-2. View

LOOMIS T, Johnson D . Aging and reversal of soman-induced effects on neuromuscular function with oximes in the presence of dimethyl sulfoxide. Toxicol Appl Pharmacol. 1966; 8(3):533-9. DOI: 10.1016/0041-008x(66)90065-2. View

Adams 3rd G, Yamamura H, OLeary J . Recovery of central respiratory function following anticholinesterase intoxication. Eur J Pharmacol. 1976; 38(1):101-12. DOI: 10.1016/0014-2999(76)90206-5. View

Smith A, Muir A . Antidotal action of the oxime HS6 at the soman poisoned neuromuscular junction of the rat and guinea-pig. J Pharm Pharmacol. 1977; 29(12):762-4. DOI: 10.1111/j.2042-7158.1977.tb11458.x. View

Sidell F . Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol. 1974; 7(1):1-17. DOI: 10.3109/15563657408987971. View

Sharma R, Watanabe P . Time related disposition of tri-O-tolyl phosphate (TOTP) and metabolites in chicken. Pharmacol Res Commun. 1974; 6(5):475-84. DOI: 10.1016/s0031-6989(74)80057-3. View

10.

Harris L, BRASWELL L, FLEISHER J, CLIFF W . METABOLITES OF PINACOLYL METHYLPHOSPHONOFLUORIDATE (SOMAN) AFTER ENZYMATIC HYDROLYSIS IN VITRO. Biochem Pharmacol. 1964; 13:1129-36. DOI: 10.1016/0006-2952(64)90113-3. View

11.

MEETER E, Wolthuis O . The spontaneous recovery of respiration and neuromuscular transmission in the rat after anticholinesterase poisoning. Eur J Pharmacol. 1968; 2(5):377-86. DOI: 10.1016/0014-2999(68)90189-1. View

12.

Wolthuis O, Visser R . The dependence of the blood level of the oxime HS-6 on the severity of organophosphate poisoning. Eur J Pharmacol. 1976; 39(2):417-21. DOI: 10.1016/0014-2999(76)90155-2. View

13.

FLEISHER J, Harris L, Prudhomme C, BURSEL J . Effects of ethyl p-nitrophenyl thionobenzene phosphonate (EPN) on the toxicity of isopropyl methyl phosphonofluoridate (GB). J Pharmacol Exp Ther. 1963; 139:390-6. View

14.

Casida J, Eto M, BARON R . Biological activity of a trio-cresyl phosphate metabolite. Nature. 1961; 191:1396-7. DOI: 10.1038/1911396a0. View

15.

Lauwerys R, Murphy S . Interaction between paraoxon and tri-o-tolyl phosphate in rats. Toxicol Appl Pharmacol. 1969; 14(2):348-57. DOI: 10.1016/0041-008x(69)90116-1. View

16.

LOOMIS T, Salafsky B . ANTIDOTAL ACTION OF PYRIDINIUM OXIMES IN ANTICHOLINESTERASE POISONING; COMPARATIVE EFFECTS OF SOMAN, SARIN, AND NEOSTIGMINE ON NEUROMUSCULAR FUNCTION. Toxicol Appl Pharmacol. 1963; 5:685-701. DOI: 10.1016/0041-008x(63)90062-0. View

17.

Kepner L, Wolthuis O . A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents. Eur J Pharmacol. 1978; 48(4):377-82. DOI: 10.1016/0014-2999(78)90164-4. View

18.

Heilbronn E, TOLAGEN B . TOXOGONIN IN SARIN, SOMAN AND TABUN POISONING. Biochem Pharmacol. 1965; 14:73-7. DOI: 10.1016/0006-2952(65)90059-6. View

19.

Boskovic B, Maksimovic M, Minic D . Ageing and reactivation of acetylcholinesterase inhibited with Soman and its thiocholine-like analogue. Biochem Pharmacol. 1968; 17(8):1738-41. DOI: 10.1016/0006-2952(68)90237-2. View

20.

Polak R, Cohen E . The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin. Biochem Pharmacol. 1969; 18(4):813-20. DOI: 10.1016/0006-2952(69)90051-3. View